Theoretically yes, the trial design could be viewed as more risky. but there have already been comparisons to valves on market and the metrics have come through superior. I think it shows confidence on part of the Anteris team. they know what the result is going to be.
Theoretically yes, the trial design could be viewed as more...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.10 |
Change
0.080(1.33%) |
Mkt cap ! $90.04M | |||
| Open | High | Low | Value | Volume |
| $6.00 | $6.10 | $5.80 | $44.84K | 7.567K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2401 | $6.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.44 | 3605 | 2 |
View Market Depth
| Last trade - 13.34pm 20/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |